THE INCREMENTAL PATHWAY / Chief Risk Officer
Illustrative. Adapted to your requirements.
Our 80/20 approach uses a shared structure, then tailors the priority, data, tools, controls and success measures. The balance varies with your needs; it is not a fixed scope or a promise of results.
A proposed new-market pilot creates new exposures. Under what conditions should it proceed?
Business sponsor owns the exposure; risk partner challenges; the delegated committee decides.
Approved risk appetite, proposal assumptions, control evidence, relevant incidents and dependencies.
Create scenarios, exposure pathways, control gaps and options: proceed, constrain, redesign or defer.
The accountable risk owner accepts the evidence and residual exposure. The delegated authority records the decision.
Reserve released capacity for growth scenario workshops, emerging-risk investigation and testing whether mitigations will work.
Baseline: [measure]. Trial owner: [name]. Review date: [date]. Priority receiving capacity: [priority].
Faster approval is not the goal by itself. Risk appetite, independent challenge, evidence quality and accountable acceptance remain decision gates.
Back to the Chief Risk Officer page
Illustrative scope: One new product or market approval
Core team: Business sponsor + risk partner + independent challenger
Capacity goes into: Growth decisions with clear conditions
Scale gate: Independent challenge confirms the evidence and residual exposure; decision conditions have named owners and deadlines.
Connected ownership: Product or Revenue owns the opportunity; Risk challenges the case without taking over the business decision.
Agree scope, fees, participant effort, approved data and success thresholds before starting. Adapt by business unit and region; examples are not verified client results.